Purple Biotech Ltd. (PPBT)

NASDAQ: PPBT · IEX Real-Time Price · USD
0.730
+0.033 (4.75%)
Feb 26, 2024, 12:59 PM EST - Market open

Purple Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Revenue
000010.10000
Revenue Growth (YoY)
----900.00%-----
Gross Profit
000010.10000
Selling, General & Admin
6.286.1164.395.26.431.511.271.06
Research & Development
16.3211.837.242.285.274.644.182.563.190.11
Other Operating Expenses
0000-0.741.03000.721.38
Operating Expenses
22.617.9313.246.679.7212.077.184.075.182.55
Operating Income
-22.6-17.93-13.24-6.67-8.72-11.97-7.18-4.07-5.18-2.55
Interest Expense / Income
0.070.210.060.180.580.030.060.230.350.08
Other Expense / Income
-44.34-36.53-41.3-12.92-14.5-24.17-19.37-8.5-0.27-
Pretax Income
21.6718.38286.075.212.1812.134.2-5.25-2.63
Income Tax
0000.22000000
Net Income
21.6718.38285.855.212.1812.134.2-5.25-2.63
Net Income Growth
17.86%-34.34%378.62%12.50%-57.30%0.43%188.55%---
Shares Outstanding (Basic)
17818122196100
Shares Outstanding (Diluted)
-18122196100
Shares Change
913.93%52.76%493.78%36.34%-84.98%64.30%497.99%329.53%173.08%-
EPS (Basic)
-12.00-10.10-25.00-27.50-3.90-13.70-21.10-44.00-234.00-320.00
EPS (Diluted)
-12.00-10.10-25.00-27.50-3.90-13.70-21.10-44.00-234.00-320.00
Free Cash Flow
-0.23-0.491.55-1.98-8.5-8.64-6.27-3.32-4.53-0.51
Free Cash Flow Per Share
-0.01-0.281.35-10.22-59.81-9.14-10.90-34.46-201.98-62.39
Gross Margin
----100.00%100.00%----
Operating Margin
-----872.00%-11966.00%----
Profit Margin
----520.00%12177.00%----
Free Cash Flow Margin
-----849.60%-8640.00%----
Effective Tax Rate
---3.56%------
EBITDA
21.9418.8328.36.435.7812.2112.194.43-4.91-2.55
EBITDA Margin
----578.30%12207.00%----
Depreciation & Amortization
0.20.230.240.180.0100000
EBIT
21.7418.628.066.255.7812.212.194.43-4.91-2.55
EBIT Margin
----577.60%12203.00%----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).